Loading...
XTAI
1711
Market cap793mUSD
Oct 08, Last price  
46.25TWD
1D
1.76%
1Q
8.06%
Jan 2017
129.53%
Name

Everlight Chemical Industrial Corp

Chart & performance

D1W1MN
XTAI:1711 chart
P/E
—
P/S
3.35
EPS
—
Div yield, %
0.65%
Shrs. gr., 5y
0.32%
Rev. gr., 5y
-0.52%
Revenues
7.57b
-7.34%
5,817,090,0006,869,310,0007,082,227,0006,481,482,0007,988,164,0007,334,190,0008,012,043,0008,768,980,0009,899,878,0009,537,421,0009,450,874,0009,169,480,0009,621,019,0009,332,076,0007,769,066,0009,200,988,0008,891,702,0007,861,424,0008,168,220,0007,568,574,000
Net income
-136m
L
122,223,000109,770,00090,975,000318,150,000722,250,000460,507,000502,421,000588,161,000578,435,000565,347,000468,534,000366,138,000401,983,000362,447,000213,279,000472,970,000374,432,00085,866,000243,590,000-136,155,000
CFO
735m
-24.92%
125,324,00022,210,000256,005,0001,755,427,000797,150,000494,290,000950,655,000497,786,000476,159,0001,311,880,000974,998,000939,688,000747,755,0001,290,380,0001,405,990,000757,244,000853,174,0001,280,209,000979,533,000735,456,000
Dividend
Jun 19, 20250.3 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Everlight Chemical Industrial Corporation, founded in Taipei, Taiwan, in 1972, operates as a global producer and distributor of a diverse array of chemical products. Its extensive market reach spans Taiwan, the broader Asian region, the United States, Europe, and other international territories. The company's product portfolio encompasses a comprehensive range of dyes, including those for textiles, leather, inkjet printing, metals, paper, and advanced functional chemicals for fabric applications, digital textile solutions, and solar-sensitized dyes. Furthermore, Everlight provides specialized chemical additives such as light stabilizers, crucial for enhancing the durability of weather-resistant coatings and plastics, alongside anti-yellowing agents for polyurethane and thermoplastic polyurethane materials, and essential raw materials for sunscreen cosmetic formulations. In the pharmaceutical sector, it develops and manufactures active pharmaceutical ingredients (APIs), notably prostaglandin APIs, as well as APIs for treating cardiovascular conditions and Parkinson's disease. For the electronics industry, the corporation supplies high-performance materials like photoresists, developers, polishing solutions, and sophisticated functional surface nano-coatings designed for integrated circuits (ICs), liquid crystal displays (LCDs), light-emitting diodes (LEDs), and touch panel (TP) applications. Additionally, it produces and markets imaging consumables, including toner and cartridges, compatible with laser printers, photocopiers, and fax machines. Beyond manufacturing, the company actively engages in the trading of chemical products and raw materials, offers expert technical consulting services, and produces pigments, toners, and specialized chemicals for electronic applications.

Key people

Chien-Hsin Chen
Chairman of the Board · since 2009
Wei-Wang Chen
General Manager, Director · since 2001
Deputy General Manager · since 2019
Qing-Tai Chen
Deputy General Manager · since 2019
Fu-Xing Lee
Deputy General Manager · since 2020
Jen-Yang Liang
Deputy General Manager · since 2023
Zhao-Wen Lin
Deputy General Manager, Director · since 2024
Kun-Mu Chen
Plant Manager-Plant I · since 2021
Yi-Zhong Du
Special Assistant to Chairman · since 2020
Yuan-Sheng Kang
Plant Manager-Plant III · since 2017
Ming-Wen Li
Corporate Governance Officer · since 2021
Kuo-Pin Weng
Head of Finance & Accounting · since 2010
Shun-Xing Yeh
Plant Manager-Plant II · since 2020
Chien-Ming Chen
Director · since 2006
Ju-Ai Chen
Director · since 2024
Ding-Chi Chen
Director · since 1972
Director · since 2000
Director · since 1994
Yuan-Jan Chang
Independent Director · since 2021
Shu-Yu Lin
Independent Director · since 2024
IPO date
Dec 27, 1988
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT